Peripheral Artery Disease (PAD)

This channel includes news, interventions, and new technology innovations for peripheral artery diease, PAD and critical limb ischemia. 

The Boston Scientific Eluvia self-expanding, drug-eluting peripheral stent. It outperformed the Cook Zilver stent in the IMPERIAL Trial presented at TCT 2018.
Feature | Peripheral Artery Disease (PAD) | Dave Fornell, Editor

In recent years, there has been a lot of focus by vendors on developing better stenting technologies to treat peripheral ...

Home January 30, 2019
Home
News | Drug-Eluting Balloons

January 28, 2019 — Philips announced the latest pooled analysis of patient-level data of over 2,300 patients treated ...

Home January 28, 2019
Home
The safety of paclitaxel-eluting stents and drug-coated balloons was called into question in a recent study that showed higher mortality rates after two years. The Cook Zilver PTX paclitaxel-eluting peripheral stent is among the devices included in that study.
Feature | Peripheral Artery Disease (PAD) | Dave Fornell, Editor

The anti-proliferative drug paclitaxel has been used as a coating on coronary stents to prevent restenosis since 2003 ...

Home January 25, 2019
Home
News | Peripheral Artery Disease (PAD)

January 25, 2019 — Profusa announced promising clinical data from two studies evaluating the company's Lumee Oxygen ...

Home January 25, 2019
Home
News | Peripheral Artery Disease (PAD)

January 23, 2019 — A new report in the Journal of Vascular Surgery chronicles a multi-site randomized controlled trial c ...

Home January 23, 2019
Home
News | Peripheral Artery Disease (PAD)

January 17, 2019 — The U.S. Food and Drug Administration (FDA) issued a letter Jan. 17, 2019, to healthcare providers ...

Home January 17, 2019
Home
News | Peripheral Artery Disease (PAD)

December 19, 2018 — A new set of appropriate use criteria (AUC) released Dec. 17 by a group of cardiovascular ...

Home December 19, 2018
Home
News | Catheters

December 18, 2018 — Merit Medical Systems Inc. announced that it has acquired substantially all of the assets of ...

Home December 18, 2018
Home
News | Cath Lab

December 14, 2018 – Shockwave Medical announced a new investment and collaboration agreement with Abiomed Inc. As ...

Home December 14, 2018
Home
News | Peripheral Artery Disease (PAD)

December 4, 2018 — New results from the DISRUPT PAD II study showed no perforations, embolization, reflow or abrupt ...

Home December 04, 2018
Home
News | Peripheral Artery Disease (PAD)

November 9, 2018 — VentureMed Group Inc. announced the initiation of a new study to determine if the Flex Dynamic ...

Home November 09, 2018
Home
News | Peripheral Artery Disease (PAD)

November 7, 2018 — The Lutonix Drug-Coated Balloon (DCB) showed statistically significant safety equivalence with a ...

Home November 07, 2018
Home
Videos

Professor Ian Meredith, MBBS, Ph.D., global chief medical officer and executive vice president, Boston Scientific ...

Home October 11, 2018
Home
Technology | Stents Peripheral

October 5, 2018 — Veryan Medical Ltd has received Premarket Approval (PMA) for the BioMimics 3D Vascular Stent System ...

Home October 05, 2018
Home
Technology | Stents Drug Eluting

October 1, 2018 — Boston Scientific announced that the U.S. Food and Drug Administration (FDA) has approved its ...

Home October 01, 2018
Home
Subscribe Now